Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 4
1991 3
1992 3
1993 17
1994 19
1995 21
1996 44
1997 46
1998 43
1999 66
2000 74
2001 62
2002 80
2003 79
2004 76
2005 91
2006 78
2007 87
2008 80
2009 75
2010 83
2011 69
2012 64
2013 79
2014 73
2015 81
2016 87
2017 60
2018 58
2019 51
2020 46
2021 33
2022 22
2023 17
2024 15
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,720 results

Results by year

Filters applied: . Clear all
Page 1
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis.
Hirano I, Safroneeva E, Roumet MC, Comer GM, Eagle G, Schoepfer A, Falk GW. Hirano I, et al. Aliment Pharmacol Ther. 2020 Apr;51(8):750-759. doi: 10.1111/apt.15670. Epub 2020 Mar 9. Aliment Pharmacol Ther. 2020. PMID: 32149424 Clinical Trial.
BACKGROUND: APT-1011, a fluticasone propionate orally disintegrating tablet formulation, is under investigation for the treatment of eosinophilic oesophagitis (EoE). ...
BACKGROUND: APT-1011, a fluticasone propionate orally disintegrating tablet formulation, is under investigation for the treatment of …
Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial.
Malone A, Kowalski MM, Helliwell J, Lynggaard Boll S, Rovsing H, Moriat K, Castillo Mondragón A, Li Y, Prener Miller C, Reinstrup Bihlet A, Dobek C, Peck V, Wilmink M, Simon LS, Conaghan PG. Malone A, et al. Lancet Rheumatol. 2024 Dec;6(12):e860-e870. doi: 10.1016/S2665-9913(24)00223-6. Epub 2024 Oct 11. Lancet Rheumatol. 2024. PMID: 39401503 Free article. Clinical Trial.
EP-104IAR, a long-acting formulation of fluticasone propionate for intra-articular injection, optimises the action of fluticasone propionate through novel diffusion-based extended-release technology. ...Safety, including laboratory analyses, and pharmacokinetics fro …
EP-104IAR, a long-acting formulation of fluticasone propionate for intra-articular injection, optimises the action of fluticasone …
Effect of fluticasone-impregnated throat packs on postoperative sore throat (POST) and hoarseness of voice: A randomized clinical trial.
Talapatra A, Mathew S, Kanakalakshmi ST, Rani R. Talapatra A, et al. F1000Res. 2024 Jun 10;12:1352. doi: 10.12688/f1000research.139742.2. eCollection 2023. F1000Res. 2024. PMID: 38434667 Free PMC article. Clinical Trial.
This study aimed to determine the effect of fluticasone-impregnated versus saline throat packs on the occurrence and severity of POST and voice hoarseness. ...Patients were randomized to groups based on a computer-generated table of random numbers post-intubation after pla …
This study aimed to determine the effect of fluticasone-impregnated versus saline throat packs on the occurrence and severity of POST …
Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial.
Płoszczuk A, Bosheva M, Spooner K, McIver T, Dissanayake S. Płoszczuk A, et al. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618777924. doi: 10.1177/1753466618777924. Ther Adv Respir Dis. 2018. PMID: 29857783 Free PMC article. Clinical Trial.
The study objectives were to demonstrate superiority of fluticasone/formoterol to fluticasone and non-inferiority to fluticasone/salmeterol. RESULTS: A total of 512 patients were randomized: fluticasone/formoterol, 169; fluticasone, 173; flut …
The study objectives were to demonstrate superiority of fluticasone/formoterol to fluticasone and non-inferiority to flutic …
Comparing Budesonide and Fluticasone Propionate in Children with Moderate to Severe Asthma: A Pilot Randomized Controlled Trial.
Sadeghzadeh M, Khoshnevisasl P, Ahmadiafshar A, Motamed N, Pourmarjani A. Sadeghzadeh M, et al. Iran J Allergy Asthma Immunol. 2023 Dec 28;22(6):527-535. doi: 10.18502/ijaai.v22i6.14642. Iran J Allergy Asthma Immunol. 2023. PMID: 38477950 Free article. Clinical Trial.
This study aimed to compare the effects of fluticasone propionate (FP) and budesonide (Bud) on the clinical symptoms and control of asthma in children with moderate to severe asthma. ...Additionally, the requirement for salbutamol use was notably reduced in the fluticas …
This study aimed to compare the effects of fluticasone propionate (FP) and budesonide (Bud) on the clinical symptoms and control of a …
Clinical efficacy and safety of fluticasone/salmeterol inhalation powder combined with huaiqihuang granules in the treatment of children with cough variant asthma.
Liu J, Yang J, Du S, Guo R, Guo Y, Gao C, Xi R, Chen C. Liu J, et al. Pak J Pharm Sci. 2023 May;36(3(Special)):1001-1007. Pak J Pharm Sci. 2023. PMID: 37587710 Clinical Trial.
This study was to evaluate the clinical efficacy and safety of fluticasone/ salmeterol inhalation powder plus Huaiqihuang Granules for children with cough variant asthma (CVA). From June 2019 to May 2021, 60 children with CVA were hospitalized to the Pediatrics Department …
This study was to evaluate the clinical efficacy and safety of fluticasone/ salmeterol inhalation powder plus Huaiqihuang Granules fo …
Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
Sher LD, Yiu G, Sakov A, Liu S, Caracta CF. Sher LD, et al. Allergy Asthma Proc. 2017 Sep 21;38(5):343-353. doi: 10.2500/aap.2017.38.4069. Epub 2017 Jun 21. Allergy Asthma Proc. 2017. PMID: 28639542 Clinical Trial.
BACKGROUND: A novel, inhalation-driven, multidose dry powder inhaler (MDPI) has been developed, which allows for lower doses of fluticasone propionate (Fp) and Fp/salmeterol (FS) for the treatment of patients with asthma. ...
BACKGROUND: A novel, inhalation-driven, multidose dry powder inhaler (MDPI) has been developed, which allows for lower doses of fluticaso …
1,720 results